National Quality Measures Clearinghouse | Cancer - dyspnea: RAND Corporation

RAND Corporation

Cancer - dyspnea: percentage of inpatients with primary lung cancer or advanced cancer with dyspnea on admission who were offered symptomatic management or treatment directed at an underlying cause within 24 hours.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of inpatients with primary lung cancer or advanced cancer with dyspnea on admission who were offered symptomatic management or treatment directed at an underlying cause within 24 hours.


Cancer - dyspnea: percentage of outpatients with primary lung cancer or advanced cancer who reported new or worsening dyspnea who were offered symptomatic management or treatment directed at an underlying cause within one month.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of outpatients with primary lung cancer or advanced cancer who reported new or worsening dyspnea who were offered symptomatic management or treatment directed at an underlying cause within one month.


Cancer - dyspnea: percentage of patients in the hospital treated for dyspnea who had an assessment within 24 hours that the treatment was effective in relieving dyspnea or that a change in treatment for dyspnea was made.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of patients in the hospital treated for dyspnea who had an assessment within 24 hours that the treatment was effective in relieving dyspnea or that a change in treatment for dyspnea was made.


Cancer - dyspnea: percentage of patients who reported new or worsening dyspnea for whom there was documentation of cause or of investigation of at least one of the following: hypoxia, anemia, bronchospasm or chronic obstructive pulmonary disease, pleural effusion, tumor obstruction of bronchi or the trachea, pneumonia, or pulmonary embolism.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of patients who reported new or worsening dyspnea for whom there was documentation of cause or of investigation of at least one of the following: hypoxia, anemia, bronchospasm or chronic obstructive pulmonary disease, pleural effusion, tumor obstruction of bronchi or the trachea, pneumonia, or pulmonary embolism.


Cancer - dyspnea: percentage of patients with a malignant pleural effusion who underwent thoracentesis for whom there was a repeat assessment of dyspnea within one week.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of patients with a malignant pleural effusion who underwent thoracentesis for whom there was a repeat assessment of dyspnea within one week.


Cancer - dyspnea: percentage of patients with dyspnea and a malignant pleural effusion who were offered thoracentesis within one month of the initial diagnosis of the effusion, or other treatment (e.g., diuresis) that resulted in a reduction in the effusion or symptomatic dyspnea.

full-text:
National Quality Measures Clearinghouse | Cancer - dyspnea: percentage of patients with dyspnea and a malignant pleural effusion who were offered thoracentesis within one month of the initial diagnosis of the effusion, or other treatment (e.g., diuresis) that resulted in a reduction in the effusion or symptomatic dyspnea.